4//SEC Filing
Bodick Neil 4
Accession 0001209191-18-040937
CIK 0001419600other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:07 PM ET
Size
8.5 KB
Accession
0001209191-18-040937
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-07-02$25.10/sh−33,508$841,192→ 78,799 total - Sale
Common Stock
2018-07-03$25.00/sh−16,492$412,300→ 62,307 total
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted May 31, 2018.
- [F2]The weighted average sale price for the transaction reported was $25.104229, and the range of prices were between $25 and $25.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001598099
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:07 PM ET
- Size
- 8.5 KB